272 related articles for article (PubMed ID: 17173870)
1. Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model.
Kang JM; Park HJ; Choi YG; Choe IH; Park JH; Kim YS; Lim S
Brain Res; 2007 Feb; 1131(1):211-9. PubMed ID: 17173870
[TBL] [Abstract][Full Text] [Related]
2. Acupuncture inhibits ferric iron deposition and ferritin-heavy chain reduction in an MPTP-induced parkinsonism model.
Choi YG; Park JH; Lim S
Neurosci Lett; 2009 Jan; 450(2):92-6. PubMed ID: 19056464
[TBL] [Abstract][Full Text] [Related]
3. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
[TBL] [Abstract][Full Text] [Related]
4. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice.
Kang JM; Jung JC; Kim H; Lim H; Jang S; Oh S
Arch Pharm Res; 2008 Sep; 31(9):1098-107. PubMed ID: 18806951
[TBL] [Abstract][Full Text] [Related]
6. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
[TBL] [Abstract][Full Text] [Related]
7. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in Parkinson models varies with toxin administration protocol.
Anderson DW; Bradbury KA; Schneider JS
Eur J Neurosci; 2006 Dec; 24(11):3174-82. PubMed ID: 17156378
[TBL] [Abstract][Full Text] [Related]
9. Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure.
Barcia C; Sánchez Bahillo A; Fernández-Villalba E; Bautista V; Poza Y Poza M; Fernández-Barreiro A; Hirsch EC; Herrero MT
Glia; 2004 May; 46(4):402-9. PubMed ID: 15095370
[TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
11. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
[TBL] [Abstract][Full Text] [Related]
12. Cellular distribution of interleukin-1alpha-immunoreactivity after MPTP intoxication in mice.
Hébert G; Mingam R; Arsaut J; Dantzer R; Demotes-Mainard J
Brain Res Mol Brain Res; 2005 Aug; 138(2):156-63. PubMed ID: 15922486
[TBL] [Abstract][Full Text] [Related]
13. Microglial activation and age-related dopaminergic neurodegeneration in MPTP-treated SAMP8 mice.
Liu J; Wang MW; Gu P; Ma QY; Wang YY; Geng Y; Yuan ZY; Cui DS; Zhang ZX; Ma L; Zhang BH; Zhou MG; Zhu AP
Brain Res; 2010 Jul; 1345():213-20. PubMed ID: 20546706
[TBL] [Abstract][Full Text] [Related]
14. Long-lasting reactive changes observed in microglia in the striatal and substantia nigral of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Yasuda Y; Shinagawa R; Yamada M; Mori T; Tateishi N; Fujita S
Brain Res; 2007 Mar; 1138():196-202. PubMed ID: 17275793
[TBL] [Abstract][Full Text] [Related]
15. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model.
Jeon S; Kim YJ; Kim ST; Moon W; Chae Y; Kang M; Chung MY; Lee H; Hong MS; Chung JH; Joh TH; Lee H; Park HJ
Proteomics; 2008 Nov; 8(22):4822-32. PubMed ID: 18942673
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson's disease.
Rojo AI; Innamorato NG; Martín-Moreno AM; De Ceballos ML; Yamamoto M; Cuadrado A
Glia; 2010 Apr; 58(5):588-98. PubMed ID: 19908287
[TBL] [Abstract][Full Text] [Related]
18. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson's disease.
Kim JI; Yang EJ; Lee MS; Kim YS; Huh Y; Cho IH; Kang S; Koh HK
Int J Neurosci; 2011 Apr; 121(4):209-17. PubMed ID: 21265705
[TBL] [Abstract][Full Text] [Related]
19. Estrogen reduces BDNF level, but maintains dopaminergic cell density in the striatum of MPTP mouse model.
Tripanichkul W; Gerdprasert O; Jaroensuppaperch EO
Int J Neurosci; 2010 Jul; 120(7):489-95. PubMed ID: 20583901
[TBL] [Abstract][Full Text] [Related]
20. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
